Abstract

The most obvious, if not the only route, by which a chemical substance can be carried to a tumour, is, of course, by its vascular supply. Preliminary investigation using a timed intra-arterial injection method appeared to show good and uniform distribution of the dye, patent blue violet, throughout widely scattered malignant melanomata. This even penetration of dye stuff to cutaneous aspects of the tumour was at variance with the observation of erratic regression of disease which sometimes follows chemotherapy not only in patients with essentially similar tumours but even where adjacent tumour nodules in the same region respond in a markedly different manner. One explanation for this could be the varying degrees of access of the therapeutic agent to different parts of the tumour by reason of inequality of blood supply. Conventional arteriography cannot give an entirely accurate picture of tumour blood supply for technical reasons. In the first place, the contrast medium is usually injected rapidly and with considerable force—a state of affairs which does not apply physiologically, and secondly, the contrast medium is rather viscous and heavy. Only the vessels themselves can be shown by this method and even then, there is a limit to the smallest calibre which can be demonstrated. The distribution of the blood within the tumour is not visualised and it is here that dye and fluorescent studies give much fuller and more helpful information.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.